SI9720063A - Postopek za proizvodnjo IgM preparata za intravenozno aplikacijo - Google Patents

Postopek za proizvodnjo IgM preparata za intravenozno aplikacijo Download PDF

Info

Publication number
SI9720063A
SI9720063A SI9720063A SI9720063A SI9720063A SI 9720063 A SI9720063 A SI 9720063A SI 9720063 A SI9720063 A SI 9720063A SI 9720063 A SI9720063 A SI 9720063A SI 9720063 A SI9720063 A SI 9720063A
Authority
SI
Slovenia
Prior art keywords
igm
protein
protease
suspension
aqueous solution
Prior art date
Application number
SI9720063A
Other languages
English (en)
Slovenian (sl)
Inventor
Markus Rentsch
Original Assignee
Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk filed Critical Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk
Publication of SI9720063A publication Critical patent/SI9720063A/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SI9720063A 1996-10-14 1997-10-14 Postopek za proizvodnjo IgM preparata za intravenozno aplikacijo SI9720063A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96810690A EP0835880A1 (de) 1996-10-14 1996-10-14 Verfahren zur Herstellung eines IgM Präparates für die intravenöse Applikation
PCT/CH1997/000388 WO1998016558A1 (de) 1996-10-14 1997-10-14 VERFAHREN ZUR HERSTELLUNG EINES IgM-PRÄPARATES FÜR DIE INTRAVENÖSE APPLIKATION

Publications (1)

Publication Number Publication Date
SI9720063A true SI9720063A (sl) 1999-08-31

Family

ID=8225725

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9720063A SI9720063A (sl) 1996-10-14 1997-10-14 Postopek za proizvodnjo IgM preparata za intravenozno aplikacijo

Country Status (19)

Country Link
US (1) US6136312A (ja)
EP (1) EP0835880A1 (ja)
JP (1) JP2001504092A (ja)
KR (1) KR20000048826A (ja)
CN (1) CN1233258A (ja)
AU (1) AU725134B2 (ja)
BR (1) BR9712306A (ja)
CA (1) CA2266848A1 (ja)
CZ (1) CZ125599A3 (ja)
HU (1) HUP0001069A3 (ja)
ID (1) ID21364A (ja)
IL (1) IL129383A0 (ja)
NO (1) NO991733L (ja)
NZ (1) NZ334885A (ja)
PL (1) PL332774A1 (ja)
RU (1) RU2191032C2 (ja)
SI (1) SI9720063A (ja)
SK (1) SK46699A3 (ja)
WO (1) WO1998016558A1 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8142780B2 (en) * 1998-08-20 2012-03-27 Strox Biopharmaceuticals, Llc Anti-bacterial antibodies
DE602004030451D1 (de) 2003-07-15 2011-01-20 Chugai Pharmaceutical Co Ltd Produktion von igm durch transformierte zellen und verfahren zur quantifizierung dieser igm-produktion
WO2005035574A1 (ja) * 2003-10-09 2005-04-21 Chugai Seiyaku Kabushiki Kaisha IgM高濃度安定化溶液
WO2005035573A1 (ja) * 2003-10-09 2005-04-21 Chugai Seiyaku Kabushiki Kaisha タンパク質溶液の安定化方法
PT1981540E (pt) * 2006-01-30 2013-05-07 Grifols Therapeutics Inc Método de tratamento e profilaxia de doenças relacionadas com a deposição de amilóides utilizando igm
FR2899111B1 (fr) * 2006-03-31 2010-09-03 Lab Francais Du Fractionnement Concentre d'immunoglobulines specifiques du chikungunya en tant que medicament.
JP2011519974A (ja) * 2008-05-12 2011-07-14 ストロックス バイオファーマスーティカルズ，エルエルシー 黄色ブドウ球菌（Ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）に特異的な抗体製剤
CN101721633B (zh) * 2008-10-16 2011-12-21 岳道友 一种促进动物生长的中草药
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
RU2470664C2 (ru) * 2010-08-23 2012-12-27 Андрей Германович Лютов Способ получения иммуноглобулина для внутривенного введения, обогащенного иммуноглобулином м, и препарат, полученный этим способом
AU2015271749B2 (en) 2014-06-03 2018-03-01 Xbiotech Inc. Compositions and methods for treating and preventing Staphylococcus aureus infections
UY39318A (es) * 2020-07-10 2022-02-25 Grifols Worldwide Operations Ltd Procedimiento para obtener una composicion que comprende inmunoglobulina m derivada de plasma humano

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075193A (en) * 1976-11-26 1978-02-21 Parke, Davis & Company Process for producing intravenous immune globulin
DE2901822A1 (de) * 1979-01-18 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung einer fuer die intravenoese applikation geeigneten immunglobulinloesung, die igm in ankonzentrierter form enthaelt
AT383739B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen
IT1186766B (it) * 1985-11-08 1987-12-16 Sclavo Spa Metodo per la preparazione di immunoglobuline per uso endovenoso
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
DE3927112C1 (ja) * 1989-08-17 1990-10-25 Biotest Pharma Gmbh, 6072 Dreieich, De
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate

Also Published As

Publication number Publication date
AU725134B2 (en) 2000-10-05
AU4449597A (en) 1998-05-11
KR20000048826A (ko) 2000-07-25
HUP0001069A2 (hu) 2000-10-28
SK46699A3 (en) 2000-06-12
IL129383A0 (en) 2000-02-17
EP0835880A1 (de) 1998-04-15
NO991733L (no) 1999-06-11
CN1233258A (zh) 1999-10-27
HUP0001069A3 (en) 2000-12-28
RU2191032C2 (ru) 2002-10-20
ID21364A (id) 1999-05-27
BR9712306A (pt) 1999-08-31
JP2001504092A (ja) 2001-03-27
CA2266848A1 (en) 1998-04-23
PL332774A1 (en) 1999-10-11
CZ125599A3 (cs) 1999-07-14
NZ334885A (en) 2000-09-29
WO1998016558A1 (de) 1998-04-23
NO991733D0 (no) 1999-04-13
US6136312A (en) 2000-10-24

Similar Documents

Publication Publication Date Title
Waldmann et al. Metabolism of immunoglobulins
US5886154A (en) Chromatographic method for high yield purification and viral inactivation of antibodies
EP2272870B1 (en) Process for manufacturing immunoglobulins for intravenous administration and other immunoglobulin-like products
EP0073371B1 (en) Intravenously injectable immune serum globulin and method of preparing same
DE68903558T2 (de) Verfahren zur inaktivierung von viren.
DE3825429C2 (de) Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
EP0447585B1 (de) Verfahren zur Herstellung eines intravenös verträglichen Immunglobulin-G-Präparates
SI9720063A (sl) Postopek za proizvodnjo IgM preparata za intravenozno aplikacijo
US4318902A (en) Concentrated immunoglobulin solution suited for intravenous administration
KR960006939A (ko) 분배제로서 카프릴산 나트륨을 사용하는 저온 알부민 분별법
DE3927111A1 (de) Nicht modifizierte intravenoes verabreichbare igm- und/oder iga-haltige immunglobulinpraeparate und verfahren zu ihrer herstellung
EP0085747B2 (de) Intravenös verabreichbares humanes Immunglobulin und Verfahren zu dessen Herstellung
EP0853944B1 (de) Präparation umfassend Thiolgruppen-haltige Proteine
CA1216792A (en) Method of inactivating incompatibility-reaction- causing substances
DE3430320A1 (de) Verfahren zur herstellung von immunglobulin-praeparaten mit verminderter komplementaktivitaet
CA2161682A1 (en) Liquid globulin composition for intravenous injection, process for producing the same, and method of inhibiting globulin dimer increase in said composition
DE2311333C2 (de) Verfahren zur Herstellung eines intravenös injizierbaren modifizierten Immunserumglobulins
SK165899A3 (sk) Príprava ľudského imunoglobulínu s histamfnom